Establishment Labs Holdings Inc (ESTA) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available for investment. While the company shows strong revenue growth and positive long-term analyst sentiment, the recent price trend, technical indicators, and hedge fund selling suggest caution. The stock is oversold, but without strong positive catalysts or clear proprietary trading signals, it is better to wait for a more favorable entry point.
The stock is currently oversold with an RSI of 13.284, indicating potential for a rebound. However, the MACD is negatively expanding (-1.479), and the price is below key support levels (S1: 64.496, S2: 60.654). Moving averages are converging, suggesting indecision in the market. The overall trend is bearish.

Strong revenue growth in Q4 2025 (up 45.16% YoY).
Analysts maintain positive long-term sentiment with multiple price target increases.
Gross margin improvement to 70.46%.
Hedge funds are selling, with a 348.78% increase in selling activity last quarter.
Net income and EPS dropped significantly in Q4 2025 (-92.43% and -92.44% YoY, respectively).
No recent congress trading data or significant insider activity.
The stock is underperforming the broader market (SP500 -1.52%, ESTA -3.99%).
In Q4 2025, revenue increased by 45.16% YoY to $64.62M, indicating strong top-line growth. However, net income dropped significantly to -$2.62M (-92.43% YoY), and EPS fell to -0.09 (-92.44% YoY). Gross margin improved to 70.46%, up 2.86% YoY, showing operational efficiency.
Analysts are generally positive on ESTA, with multiple firms raising price targets recently. Citi lowered its target to $74 (Neutral), but Canaccord, Mizuho, TD Cowen, and Stephens raised targets to $90-$100, maintaining Buy/Outperform ratings. Analysts highlight strong growth potential, U.S. market share gains, and structural profitability improvements.